During the past decade, Hopital Cochin Gastro-Enterologie conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Hopital Cochin Gastro-Enterologie" are "Incurable Disease" (1 trials) and "Rheumatoid Arthritis" (1 trials). Many other conditions were trialed in "Hopital Cochin Gastro-Enterologie" in a lesser frequency.

Most popular intervention types in "Hopital Cochin Gastro-Enterologie" are "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Early consideration of vulnerability" (1 trials), "Etanercept" (1 trials), "Tocilizumab" (1 trials) and "Usual practices" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hopital Cochin Gastro-Enterologie" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Hopital Cochin Gastro-Enterologie". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Hopital Cochin Gastro-Enterologie, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hopital Cochin Gastro-Enterologie, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".